- Report
- May 2025
- 199 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- August 2024
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- September 2024
- 200 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- August 2024
- 200 Pages
Global
From €3465EUR$3,869USD£2,954GBP
- Report
- May 2025
- 188 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- July 2024
- 139 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 82 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- January 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- March 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- March 2025
- 204 Pages
North America
From €3090EUR$3,450USD£2,634GBP
- Report
- October 2023
- 165 Pages
United States
From €2239EUR$2,500USD£1,909GBP
- Report
- November 2023
- 167 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- August 2022
- 115 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- January 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- February 2024
- 305 Pages
Global
From €3986EUR$4,450USD£3,398GBP

The Neurodiagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of neurological disorders. It includes a range of technologies and services, such as imaging, EEG, EMG, and evoked potentials, to diagnose and monitor neurological conditions. Neurodiagnostics also includes the use of biomarkers to detect and monitor neurological diseases.
The Neurodiagnostics market is driven by the increasing prevalence of neurological disorders, the development of new technologies, and the growing demand for personalized medicine. Additionally, the increasing focus on preventive healthcare and the rising awareness of neurological disorders are expected to drive the market.
Some companies in the Neurodiagnostics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Medtronic, and Natus Medical. Show Less Read more